Trazodone is a prescription antidepressant in the serotonin antagonist and reuptake inhibitor (SARI) class. Clinicians commonly use it to treat major depressive disorder and, off-label, to help with sleep continuity problems such as insomnia. Known for its calming properties, trazodone can reduce anxiety, improve mood, and lessen nighttime awakenings. Like all prescription medications, it works best when taken exactly as directed and monitored over time. Learn how trazodone is used, typical dosages, side effects, and interactions—and how to access legitimate, clinician-guided care through Surgery Center of Pottsville.
Trazodone is FDA-approved for major depressive disorder (MDD). By modulating serotonin activity, it can lift mood, reduce anxiety, improve sleep quality, and decrease the physical symptoms of depression such as poor appetite and fatigue. Many patients notice less nighttime restlessness as therapy stabilizes. Because it is generally less activating than some other antidepressants, clinicians often choose trazodone when insomnia is a prominent feature of depression.
Outside its labeled use, trazodone is frequently prescribed off-label in low doses for insomnia, especially sleep maintenance insomnia (difficulty staying asleep). It can also be considered as adjunctive therapy in anxiety disorders or post-SSRI/SNRI augmentation. Off-label use should always be supervised by a licensed clinician who can weigh benefits, alternatives, and individual risk factors.
Only take trazodone exactly as prescribed. For depression with immediate-release tablets, clinicians often start around 150 mg per day, usually divided into 2–3 doses, and gradually adjust based on response and tolerability. Some patients may require up to 400 mg/day (outpatients), while higher doses are reserved for closely monitored inpatient settings. Extended-release formulations are typically taken once nightly, often starting at 150 mg, with cautious titration. Always follow your clinician’s schedule and do not change your dose on your own.
For insomnia (off-label), prescribers commonly use much lower doses—often 25–100 mg at bedtime—to minimize next-day sedation and reduce adverse effects. Because individual sensitivity varies widely, the lowest effective dose is preferred. To reduce dizziness or lightheadedness, many patients take trazodone in the evening and rise slowly from sitting or lying positions.
Take trazodone consistently, at the same time each day. Extended-release tablets are generally taken at bedtime and should be swallowed whole; do not crush or chew unless your clinician or pharmacist confirms a formulation that allows it. If gastrointestinal upset occurs, taking the medication with a light snack can help. Do not abruptly stop trazodone; your clinician can guide a gradual taper to limit withdrawal-like symptoms.
Black box warning: Antidepressants, including trazodone, may increase the risk of suicidal thoughts and behaviors in children, adolescents, and young adults—especially during the first few months of therapy or during dose changes. Watch for sudden mood shifts, increased agitation, or worsening depression, and seek immediate medical advice if these occur. Careful monitoring by a clinician is essential during initiation and titration.
Sedation and dizziness are common, particularly when starting or increasing the dose. Avoid alcohol and be cautious with other central nervous system depressants. Trazodone can cause orthostatic hypotension (a drop in blood pressure when standing), which may lead to fainting or falls—use extra caution in older adults. Until you know how trazodone affects you, avoid driving, operating machinery, or activities requiring full alertness.
Additional risks include serotonin syndrome (especially with other serotonergic drugs), rare but serious priapism (prolonged, painful erections requiring urgent care), arrhythmias/QT prolongation, hyponatremia/SIADH (more common in older adults), and increased bleeding risk when combined with NSAIDs, aspirin, or anticoagulants. Use caution if you have heart disease, a history of bipolar disorder (risk of mania/hypomania), narrow-angle glaucoma, seizures, liver or kidney impairment, or if you are pregnant or breastfeeding—your clinician can discuss risk–benefit and monitoring plans tailored to you.
Do not use trazodone if you have a known hypersensitivity to trazodone or any component of the formulation. Avoid trazodone with monoamine oxidase inhibitors (MAOIs) or within 14 days of stopping an MAOI, due to the risk of severe interactions (including hypertensive crisis and serotonin syndrome). Use extreme caution—and specialist guidance—if linezolid or intravenous methylene blue is required during therapy.
Common side effects include drowsiness, dizziness, dry mouth, headache, nausea, constipation or diarrhea, blurred vision, and fatigue. Many of these improve as your body adjusts. Taking doses at bedtime and staying hydrated can reduce discomfort. If you experience next-day grogginess, discuss whether a dose adjustment or timing change is appropriate.
Serious adverse effects are uncommon but require prompt attention: chest pain, irregular heartbeat, fainting, severe dizziness, confusion, agitation, fever, shivering, muscle rigidity or tremor (possible serotonin syndrome), severe allergic reactions (rash, hives, swelling, difficulty breathing), unusual bruising/bleeding, severe hyponatremia symptoms (headache, confusion, seizures), or priapism. Seek emergency care for any life-threatening or rapidly worsening symptoms.
Never combine trazodone with MAOIs and be cautious with other serotonergic agents such as SSRIs, SNRIs, TCAs, triptans, tramadol, linezolid, lithium, or St. John’s wort due to the risk of serotonin syndrome. Alcohol, benzodiazepines, sleep aids, and opioids can markedly increase sedation and respiratory depression. Trazodone may also add to the blood pressure–lowering effects of antihypertensives, increasing dizziness or fainting risk.
Drugs that affect CYP3A4 can change trazodone levels: strong inhibitors (e.g., ketoconazole, ritonavir, clarithromycin, grapefruit juice) may raise levels and side effect risk; inducers (e.g., carbamazepine, phenytoin, rifampin) may reduce efficacy. Use caution with medications that prolong the QT interval (certain antiarrhythmics like amiodarone or sotalol, some antipsychotics and macrolide antibiotics) due to potential additive cardiac effects. Report all prescriptions, over-the-counter medicines, and supplements to your clinician or pharmacist to screen for interactions.
If you miss a dose, take it when you remember unless it’s close to your next scheduled dose. If it is near the time for the next dose, skip the missed dose and resume your regular schedule. Do not double doses. To avoid missed doses, set reminders and take trazodone at the same time each day as directed by your clinician.
An overdose may cause extreme drowsiness, confusion, vomiting, low blood pressure, rapid or irregular heartbeat, seizures, difficulty breathing, or serotonin syndrome. Call emergency services or Poison Control (in the U.S., 1-800-222-1222) immediately. Do not induce vomiting unless instructed by a professional. Overdose risk and severity increase with alcohol, benzodiazepines, opioids, or other sedatives—store trazodone securely and never share your medication.
Store trazodone at room temperature (generally 68–77°F/20–25°C), away from excess heat, moisture, and direct light. Keep it in its original, child-resistant container, tightly closed, and out of reach of children and pets. Do not use expired medication. For safe disposal, use a local drug take-back program or follow FDA/DEA guidance—avoid flushing unless specifically instructed.
In the United States, trazodone is a prescription-only medication. It is not legal or safe to buy trazodone without a valid prescription. Unregulated online sources that advertise “no-prescription” sales often ship counterfeit or improperly handled medicines, increasing the risk of treatment failure, contamination, or serious harm. Protect your health by obtaining trazodone through licensed clinicians and pharmacies that verify identity, evaluate medical history, and provide ongoing monitoring.
Surgery Center of Pottsville offers a legal and structured pathway to care: you can schedule a visit (in person or via telehealth where permitted) with a licensed clinician who will assess your symptoms, review your medications and conditions, and determine whether trazodone is appropriate. When clinically indicated, prescriptions are sent to reputable, licensed pharmacies for fulfillment—no shortcuts, no gray-market vendors. This approach prioritizes your safety, ensures dose and interaction checks, supports follow-up for efficacy and side effects, and helps you stay compliant with U.S. regulations while getting the care you need.
Trazodone is a prescription antidepressant classified as a serotonin antagonist and reuptake inhibitor (SARI). It boosts serotonin activity while blocking certain serotonin receptors, which can improve mood and reduce anxiety. Its antihistaminic and alpha-1 blocking effects contribute to sedation and can help with sleep.
Trazodone is FDA-approved for major depressive disorder. Clinicians also use it off-label for insomnia, anxiety, PTSD-related sleep disturbances, and agitation in certain neurocognitive disorders. The decision to use it off-label depends on individual risks, benefits, and treatment goals.
For sleep, many people notice benefits within 30 to 60 minutes of a bedtime dose. For depression, consistent daily use is needed and improvements typically build over 2 to 4 weeks, with full effects sometimes taking 6 to 8 weeks.
For insomnia, low doses such as 25 to 100 mg at bedtime are commonly used off-label. For depression, initial dosing often starts around 150 mg per day in divided doses or as an extended-release tablet at night, with gradual increases to 150 to 400 mg daily depending on response and tolerability.
Sleepiness, dizziness, headache, dry mouth, blurred vision, constipation, and nausea are common. Some people experience orthostatic hypotension (lightheadedness on standing), which can raise fall risk, especially in older adults. Most side effects lessen as your body adjusts.
Seek urgent care for signs of serotonin syndrome (agitation, tremor, sweating, fast heartbeat, fever), severe dizziness or fainting, irregular heartbeat, severe allergic reaction, or prolonged, painful erection (priapism). Any sudden mood changes, worsening depression, or suicidal thoughts need prompt medical attention.
Trazodone is not considered addictive and does not cause craving-driven dependence like benzodiazepines or opioids. However, stopping suddenly can lead to discontinuation symptoms such as anxiety, insomnia rebound, irritability, or flu-like feelings; tapering under medical guidance helps minimize this.
Combining trazodone with alcohol, benzodiazepines, opioids, or other sedatives can amplify drowsiness, suppress breathing, and increase fall and accident risk. Most clinicians advise avoiding alcohol and using caution with any central nervous system depressants.
Avoid trazodone if you are taking or recently stopped an MAOI (within 14 days). Use caution if you have a history of bipolar disorder (risk of mania), heart rhythm problems or prolonged QT, low blood pressure, glaucoma, seizures, or are at high fall risk. Older adults may be more sensitive to sedative and blood pressure effects.
Yes. Serotonergic drugs (SSRIs, SNRIs, MAOIs, triptans, linezolid, lithium, St. John’s wort) raise serotonin syndrome risk. CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin, grapefruit) can increase trazodone levels; inducers (carbamazepine, phenytoin, rifampin) can lower them. Trazodone may increase bleeding risk with NSAIDs or anticoagulants and can affect levels of digoxin and phenytoin.
Take it exactly as prescribed, consistently at the same time each day. Many people take it at bedtime; taking with a light snack can reduce stomach upset and dizziness. Do not crush or split extended-release tablets. If switching formulations or adjusting timing with food, consult your prescriber.
Data are limited. Some people continue trazodone in pregnancy when benefits outweigh risks, but decisions should be individualized with your clinician. Small amounts pass into breast milk; monitor nursing infants for excessive sleepiness or feeding issues. Never start or stop without medical advice.
If you miss a dose and it’s close to your next dose, skip the missed one—don’t double up. Overdose can cause extreme drowsiness, low blood pressure, irregular heartbeat, or seizures; seek emergency care and contact poison control if an overdose is suspected.
It can help with sleep initiation and maintenance, especially when insomnia coexists with depression or anxiety. Long-term effectiveness varies, and sedation/tolerance profiles differ from traditional hypnotics. Combining medication with sleep hygiene and cognitive behavioral therapy for insomnia generally yields better, more durable results.
Some people feel jittery or more anxious during the first days to weeks of treatment as the body adapts. Side effects typically improve; if symptoms are severe or persistent, contact your clinician to adjust dose, timing, or consider alternatives.
Both treat major depression, but SSRIs are first-line for many patients due to robust evidence and tolerability. Trazodone is often more sedating and can help when insomnia is prominent; SSRIs tend to be activating or neutral and may cause more sexual dysfunction. Choice depends on symptoms, side effects, and prior response.
Efficacy is broadly comparable across classes for major depression, but SNRIs may help more when pain and fatigue are prominent. Trazodone offers more sedation for sleep but can cause orthostatic hypotension; venlafaxine is more likely to raise blood pressure and cause withdrawal if stopped abruptly.
Both can improve sleep. Mirtazapine is often more sedating at lower doses and may increase appetite and weight; it tends to have fewer sexual side effects. Trazodone can be used at very low doses for sleep with less weight gain but carries rare priapism risk and more orthostatic hypotension.
Bupropion is activating and often improves energy, concentration, and libido, with the lowest sexual side effect risk among antidepressants. Trazodone is better when insomnia and anxiety predominate. Bupropion may worsen anxiety in some and is contraindicated in seizure and eating disorders.
All can be sedating and help with pain-related sleep issues. Trazodone generally has fewer anticholinergic effects (dry mouth, constipation, urinary retention) and lower cardiotoxicity risk than amitriptyline at antidepressant doses. Very low-dose doxepin is an FDA-approved hypnotic with minimal next-day effects but can still cause anticholinergic side effects at higher doses.
Trazodone is not a benzodiazepine and lacks the same dependence and rebound insomnia risks. It may be less potent for acute, severe insomnia but is often preferred for chronic use when depression or anxiety coexists. Benzodiazepines work quickly but carry tolerance, dependence, and cognitive side effects.
Both can help sleep onset and maintenance, but zolpidem is a sedative-hypnotic with greater risk of dependence, complex sleep behaviors, and next-morning impairment. Trazodone is an antidepressant with lower dependence risk but may cause orthostatic hypotension and morning grogginess.
Neither is FDA-approved solely for insomnia, but both are used off-label. Quetiapine has metabolic risks (weight gain, lipid and glucose changes) and movement side effects; it is typically reserved for patients with comorbid mood or psychotic disorders. Trazodone is generally tried first when an antidepressant with sedating properties is appropriate.
Both are SARIs, but nefazodone use is limited by rare, severe liver toxicity requiring regular monitoring and caution. Trazodone lacks that boxed warning and is more commonly prescribed. Sedation and orthostatic hypotension occur with both, though profiles vary by dose.
Vortioxetine and vilazodone are multimodal serotonergic antidepressants that are usually less sedating and may have favorable cognitive or sexual side effect profiles compared with older agents. Trazodone is more sedating and better for insomnia; vortioxetine may benefit cognition in depression, while vilazodone often requires careful titration to limit GI effects.
Immediate-release is often split into multiple daily doses or used at low dose at bedtime for sleep. Extended-release provides once-daily dosing (usually at night), smoother blood levels, and potentially fewer daytime peaks and troughs; do not crush or chew ER formulations.
Both can help sleep maintenance. Low-dose doxepin targets histamine receptors with minimal next-day sedation and is FDA-approved for insomnia; it may be preferred when pure sleep maintenance is the goal. Trazodone may be chosen when coexisting depression or anxiety requires an antidepressant with sedative properties.